The discovery of a new class of synaptic transmitters in smooth muscle 50 years ago and amelioration of coronary artery thrombosis

Acta Physiologica

Volumn 207, Issue 2, 2013, Pages 236-243

  Bennett, M R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

History; Non adrenergic; Non cholinergic; Smooth muscle; Transmitters

Indexed keywords

ACETYLCHOLINE; CLOPIDOGREL; NORADRENALIN; POTASSIUM; TICAGRELOR;

CHROMATOGRAPHY; COLON TENIA; CORONARY ARTERY THROMBOSIS; CYSTIC FIBROSIS; HUMAN; MUSCLE CELL; PRIORITY JOURNAL; REVIEW; SMOOTH MUSCLE; SYNAPTIC TRANSMISSION;

ADENOSINE; ANIMALS; CORONARY ARTERY DISEASE; CORONARY THROMBOSIS; HISTORY, 20TH CENTURY; HUMANS; MUSCLE, SMOOTH; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2Y; TICLOPIDINE;

EID: 84872198677     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12039     Document Type: Review

References (58)

1. Abbracchio, M. and Burnstock, G. 1994. Purinoceptors: are there families of P2X and P2Y purinoceptors? Pharmacol Ther 64, 445-475.
2. Accurso, F.J., Moss, R.B., Wilmott, R.W., Anbar, R.D., Schaberg, A.E., Durham, T.A. and Ramsey, B.W. 2011. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function. Am J Respir Crit Care Med 183, 627-634.
3. Bartho, L., Lenard, L. Jr and Szigeti, R. 1998. Nitric oxide and ATP co-mediate the NANC relaxant response in the guinea-pig taenia caeci. Naunyn Schmiedebergs Arch Pharmacol 358, 496-499.
4. Bennett, M.R. 1965. A study of transmission from autonomic nerves to smooth muscle, Thesis for M.Sc. Melbourne University.
5. Bennett, M.R. 1966a. Model of the membrane of smooth muscle cells of the guinea-pig taenia coli muscle during transmission from inhibitory and excitatory nerves. Nature 211, 1149-1152.
6. Bennett, M.R. 1966b. Rebound excitation of the smooth muscle cells of the guinea-pig taenia coli after stimulation of intramural inhibitory nerves. J Physiol 185, 124-131.
7. Bennett, M.R. 1972. Autonomic neuromuscular transmission. Monogr Physiol Soc 30, 1-271.
8. Bennett, M.R. 1987. Optimising Research and Development in Australia. Australian Academy of Science, Canberra, ISBN 0858471388.
9. Bennett, M.R. 1997. Non-adrenergic non-cholinergic (NANC) transmission to smooth muscle: 35 years on. Prog Neurobiol 52, 159-195.
10. Bennett, M., Burnstock, G., Holman, M. and Walker, J. 1962a. The effect of calcium ions on plateau-type action potentials in smooth muscle. J Physiol 161, 47P-48P.
11. Bennett, M., Burnstock, G. and Holman, M. 1962b. The effect of ions on the electrical activity of the smooth muscle of the ureter. Proc Aust Physiol Pharmacol 20(Suppl), 46.
12. Bennett, M., Burnstock, G. and Holman, M. 1963. The effect of potassium and chloride ions on the inhibitory potential recorded in the guinea-pig taenia coli. J Physiol 169, 33P-34P.
13. Bennett, M.R., Burnstock, G. and Holman, M. 1966a. Transmission from intramural inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol 182, 541-558.
14. Bennett, M.R., Burnstock, G. and Holman, M.E. 1966b. Transmission from perivascular inhibitory nerves to the smooth muscle of the guinea-pig taenia coli. J Physiol 182, 527-540.
15. Burnstock, G. 2004. A moment of excitement. Physiol News, 56, 1-2.
16. Burnstock, G. and Kennedy, C. 1985. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol 16, 433-440.
17. Burnstock, G., Campbell, G., Bennett, M. and Holman, M.E. 1963. Inhibition of the smooth muscle of the taenia coli. Nature 200, 581-582.
18. Burnstock, G., Campbell, G., Bennett, M. and Holman, M.E. 1964. Inhibition of the guinea-pig taenia coli: are there intrinsic inhibitory nerves which are distinct from sympathetic nerves? Int J Neuropharmacol 3, 163-166.
19. Burnstock, G., Campbell, G., Satchell, D. and Smythe, A. 1970. Evidence that adenosine triphosphate or a related nucleotide is the transmitter substance released by non-adrenergic inhibitory nerves in the gut. Br J Pharmacol 40, 668-688.
20. Burnstock, G., Fredholm, B.B., North, R.A. and Verkhratsky, A. 2010. The birth and postnatal development of purinergic signalling. Acta Physiol (Oxf) 199, 93-147.
21. Campbell, G. 1966. The inhibitory nerve fibres in the vagal supply to the guinea-pig stomach. J Physiol 185, 600-612.
22. Campbell, G. 1969. The autonomic innervation of the stomach of a toad (Bufo marinus). Comp Biochem Physiol 31, 693-706.
23. Campbell, G. 1970. Autonomic nerve supply to effector tissues. In: E. Bulbring and A.F. Brading (eds) Smooth Muscle, pp. 451-495. Edward Arnold, London.
24. Cattaneo, M. 2011. The platelet P2Y receptor for adenosine diphosphate: congenital and drug-induced defects. Blood 117, 2102-2112.
25. Dale, H. 1937. Transmission of nervous effects by acetylcholine. Harvey Lect 32, 229-245.
26. Del Castillo, J. and Katz, B. 1957. Modifications de la membrane produites par des influx nerveux dans la ref on du pacermaker der coeur. Microphysiologie comparee des elements excitables. Colloq Int CNRS (Paris) 67, 271-279.
27. Deterding, R., Retsch-Bogart, G., Milgram, L., Gibson, R., Daines, C., Zeitlin, P.L., Milla, C., Marshall, B., Lavange, L., Engels, J., Mathews, D., Gorden, J., Schaberg, A., Williams, J. and Ramsey, B. 2005. Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis. Pediatr Pulmonol 39, 339-348.
28. Durnin, L., Hwang, S.J., Ward, S.M., Sanders, K.M. and Mutafova-Yambolieva, V.N. 2012. Adenosine 5-diphosphate-ribose is a neural regulator in primate and murine large intestine along with beta-NAD(+). J Physiol 590, 1921-1941.
29. Furchgott, R.F. 1996. The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide. JAMA 276, 1186-1188.
30. Gillespie, J.S. 1962. Spontaneous mechanical and electrical activity of stretched and unstretched intestinal smooth muscle cells and their response to sympathetic-nerve stimulation. J Physiol 162, 54-75.
31. Goyal, R.K. 2011. Evidence for beta-nicotinamide adenine dinucleotide as a purinergic, inhibitory neurotransmitter in doubt. Gastroenterology 141, e27; author reply e27-8.
32. Goyal, R.K. and Chaudhury, A. 2008. Physiology of normal esophageal motility. J Clin Gastroenterol 42, 610-619.
33. Huber, K., Hamad, B. and Kirkpatrick, P. 2011. Ticagrelor. Nat Rev Drug Discov 10, 255-256.
34. Huxley, A.F. and Stampfli, R. 1951. Direct determination of membrane resting potential and action potential in single myelinated nerve fibers. J Physiol 112, 476-495.
35. Jacobson, K.A., Deflorian, F., Mishra, S. and Costanzi, S. 2011. Pharmacochemistry of the platelet purinergic receptors. Purinergic Signal 7, 305-324.
36. Kellerman, D., Evans, R., Mathews, D. and Shaffer, C. 2002. Inhaled P2Y2 receptor agonists as a treatment for patients with cystic fibrosis lung disease. Adv Drug Deliv Rev 54, 1463-1474.
37. Kennedy, C. and Burnstock, G. 1985. Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol 111, 49-56.
38. King, B.F. and Townsend-Nicholson, A. 2008. Involvement of P2Y1 and P2Y11 purinoceptors in parasympathetic inhibition of colonic smooth muscle. J Pharm Exp Ther 324, 1055-1063.
39. Knowles, M.R., Clarke, L.L. and Boucher, R.C. 1991. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 325, 533-538.
40. Lemon, G., Gibson, W.G. and Bennett, M.R. 2003a. Metabotropic receptor activation, desensitization and sequestration-I: modelling calcium and inositol 1, 4, 5-trisphosphate dynamics following receptor activation. J Theor Biol 223, 93-111.
41. Lemon, G., Gibson, W.G. and Bennett, M.R. 2003b. Metabotropic receptor activation, desensitization and sequestration-II: modelling the dynamics of the pleckstrin homology domain. J Theor Biol 223, 113-129.
42. Lemon, G., Brockhausen, J., Li, G.H., Gibson, W.G. and Bennett, M.R. 2005. Calcium mobilization and spontaneous transient outward current characteristics upon agonist activation of P2Y2 receptors in smooth muscle cells. Biophys J 88, 1507-1523.
43. Marczewski, M.M., Postula, M. and Kosior, D. 2010. Novel antiplatelet agents in the prevention of cardiovascular complications-focus on ticagrelor. Vasc Health Risk Manag 6, 419-429.
44. Martinson, J. 1965. Vagal relaxation of the stomach. Experimental re-investigation of the concept of the transmission mechanism. Acta Physiol Scand 64, 453-462.
45. Mason, S.J., Paradiso, A.M. and Boucher, R.C. 1991. Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium. Br J Pharmacol 103, 1649-1656.
46. Michelsen, K.A., Van Den Hove, D.L., Schmitz, C., Segers, O., Prickaerts, J. and Steinbusch, H.W. 2007. Prenatal stress and subsequent exposure to chronic mild stress influence dendritic spine density and morphology in the rat medial prefrontal cortex. BMC Neurosci 8, 107.
47. Mutafova-Yambolieva, V.N., Hwang, S.J., Hao, X., Chen, H., Zhu, M.X., Wood, J.D., Ward, S.M. and Sanders, K.M. 2007. Beta-nicotinamide adenine dinucleotide is an inhibitory neurotransmitter in visceral smooth muscle. Proc Natl Acad Sci U S A 104, 16359-16364.
48. Nawarskas, J.J. and Clark, S.M. 2011. Ticagrelor: a novel reversible oral antiplatelet agent. Cardiol Rev 19, 95-100.
49. Nicholas, R.A. 2001. Identification of the P2Y(12) receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 60, 416-420.
50. Parr, C.E., Sullivan, D.M., Paradiso, A.M., Lazarowski, E.R., Burch, L.H., Olsen, J.C., Erb, L., Weisman, G.A., Boucher, R.C. and Turner, J.T. 1994. Cloning and expression of a human P2U nucleotide receptor, a target for cystic fibrosis pharmacotherapy. Proc Natl Acad Sci USA 91, 13067.
51. Persson, P.B. and Henriksson, J. 2011. Good publication practice in physiology. Acta Physiol (Oxf) 203, 403-407.
52. Porto, I., Giubilato, S., De Maria, G.L., Biasucci, L.M. and Crea, F. 2009. Platelet P2Y12 receptor inhibition by thienopyridines: status and future. Expert Opin Investig Drugs 18, 1317-1332.
53. Satchell, D.G. and Maguire, M.H. 1975. Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coli. J Pharmacol Exp Ther 195, 540-548.
54. Satchell, D.G. and Maguire, M.H. 1982. Evidence for separate receptors for ATP and adenosine in the guinea-pig taenia coli. Eur J Pharmacol 81, 669-672.
55. Shand, J.A., Menown, I.B. and Storey, R.F. 2011. Ticagrelor: from concept to clinical evaluation. Biomark Med 5, 53-62.
56. Storey, R.F. 2001. The P2Y12 receptor as a therapeutic target in cardiovascular disease. Platelets 12, 197-209.
57. Webb, T.E., Simon, J., Krishek, B.J., Bateson, A.N., Smart, T.G., King, B.F., Burnstock, G. and Barnard, E.A. 1993. Cloning and functional expression of a brain G-protein-coupled ATP receptor. FEBS Lett 324, 219-225.
58. Xiang, Z. and Burnstock, G. 2006. Distribution of P2Y6 and P2Y12 receptor: their colocalization with calbindin, calretinin and nitric oxide synthase in the guinea pig enteric nervous system. Histochem Cell Biol 125, 327-336.